Article
Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
The Journal of antimicrobial chemotherapy - 1 Jan 2016
Schaumburg Frieder, Peters Georg, Alabi Abraham, Becker Karsten, Idelevich Evgeny A
Abstract excerpt
OBJECTIVES: Ceftaroline and ceftobiprole are new cephalosporins, which are active against MRSA by inhibiting PBP2a. Recently, high rates of resistance to ceftaroline were reported from Ghana. The objective of this study was to assess rates of resistance to ceftaroline and ceftobiprole in MRSA from Africa and to describe potential missense mutations of PBP2a. METHODS: MRSA isolates derived from Staphylococcus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
